Article: [Risk assessment and prophylactic treatment strategies for central nervous system relapse of diffuse large B-cell lymphoma].
Rinsho ketsueki] The Japanese journal of clinical hematology
2023 Volume 64, Issue 6, Page(s) 490–496
Abstract: Rituximab treatment significantly improved the outcomes of diffuse large B-cell lymphoma (DLBCL). A central nervous system (CNS) relapse remains a serious and fatal event for patients with DLBCL; therefore, the clinical question of the optimal treatment ... ...
Abstract | Rituximab treatment significantly improved the outcomes of diffuse large B-cell lymphoma (DLBCL). A central nervous system (CNS) relapse remains a serious and fatal event for patients with DLBCL; therefore, the clinical question of the optimal treatment regimen for reducing the risk of CNS relapse remains unknown. The CNS-International Prognostic Index was identified as a predictive model for CNS relapse. No factors can completely predict CNS relapse although several reports regarding high-risk factors for CNS relapse have been reported. In practice, intrathecal methotrexate (MTX) and high-dose MTX therapy have been used for CNS prophylaxis. Unfortunately, evidence of the optimal therapy for CNS prophylaxis in patients with DLBCL remains lacking. This study aimed to review CNS relapse assessment and discuss study results with clinical impacts on CNS prophylaxis treatment strategies in DLBCL. |
---|---|
MeSH term(s) | Humans ; Cyclophosphamide/therapeutic use ; Prednisone/therapeutic use ; Vincristine/therapeutic use ; Doxorubicin/therapeutic use ; Central Nervous System Neoplasms/drug therapy ; Central Nervous System Neoplasms/prevention & control ; Neoplasm Recurrence, Local/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Rituximab/therapeutic use ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/pathology ; Methotrexate/therapeutic use ; Risk Assessment ; Chronic Disease ; Central Nervous System |
Chemical Substances | Cyclophosphamide (8N3DW7272P) ; Prednisone (VB0R961HZT) ; Vincristine (5J49Q6B70F) ; Doxorubicin (80168379AG) ; Rituximab (4F4X42SYQ6) ; Methotrexate (YL5FZ2Y5U1) |
Language | Japanese |
Publishing date | 2023-07-05 |
Publishing country | Japan |
Document type | English Abstract ; Journal Article |
ZDB-ID | 390900-1 |
ISSN | 0485-1439 |
ISSN | 0485-1439 |
DOI | 10.11406/rinketsu.64.490 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1175: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 535: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.